Heart Coherence Training for Vascular Ehlers-Danlos
Treatments studied
Part of Blood & lymphatic, Genetic & congenital, Heart & circulation, Skin clinical trials.
This study tests whether a breathing and heart-rate training program (called Heart Coherence Training) can help people with Vascular Ehlers-Danlos syndrome feel better. It's done from home using your phone and a computer or tablet.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of Vascular Ehlers-Danlos syndrome (vEDS) with a COL3A1 gene change.
- You must be between 12 and 45 years old.
- You need a smartphone and another device (like a tablet or computer) with a camera and microphone.
- You must have a stable internet connection.
- You must speak English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a supervised exercise and lifestyle programme is safe and feasible for adults with vascular Ehlers-Danlos syndrome (vEDS). It aims to help you stay active and manage your health, with medical clearance and monitoring.
This study looks at how bodies with vascular Ehlers-Danlos syndrome (vEDS) process nutrients and energy differently. By comparing people with vEDS to healthy volunteers, researchers hope to find new ways to manage the condition better.
This Phase 3 study compares celiprolol (a blood vessel–related medicine) versus placebo to see which better reduces vascular risks in people with vascular Ehlers-Danlos syndrome. It requires confirmed COL3A1 genetic findings and specific imaging before starting.
This study tests a digital program led by a health coach to help people with an enlarged heart muscle improve their lifestyle and heart health. It uses a smartphone app and internet access, so you can participate from home.
This study evaluates the heart health of people with hereditary hemorrhagic telangiectasia (HHT), a condition that causes abnormal blood vessels. By participating, you help doctors understand how HHT affects the heart, which may improve future care.
This study tests a digital platform that collects your lifestyle and health data to help prevent heart disease. You may also join a 12-week program for personalized lifestyle feedback.
Hear when a new Vascular Ehlers-Danlos Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.